The ABVANTEC brand, founded in 2007 (Denmark), from 10 sister brands and 2214 competing brands. ABVANTEC is owned by Genmab, listed on the stock exchange of Etats-Unis The ISIN, the company's International Securities Identification Number, is DK0010272202. ABVANTEC belongs to the Biotechnology business sector.

ABVANTEC is a brand of Genmab (GNMSF) Share price

International deposit : 2007 Business sector Biotechnology

Share price and profitability of the share Genmab (ABVANTEC)

Buy Genmab share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 290.38

Portfolio valuation
Genmab (ABVANTEC) over 5 years* USD 499.58

Stock market history Genmab (ABVANTEC)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Genmab

See more brands of Genmab

Rival brands
ABVANTEC

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS